SPRB
Spruce Biosciences, Inc.
44.80$
-7.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.81 | 5.41 | 3.75 | 3.01 | 1.12 | 1.24 | 1.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.03 | 0.03 | 0.03 | 15.12 | – | – | – | – | – | 0.01 | – | – | – | |
| 5.81 | 5.38 | 3.75 | 3.01 | 1.12 | – | 1.22 | – | – | -0.01 | – | – | – | |
| 25.50 | 20.81 | 19.31 | 15.12 | 12.21 | 38.11 | 18.97 | 0.71 | 8.90 | 5.35 | 5.52 | 5.00 | 11.87 | |
| 6.12 | 5.53 | 8.08 | 6.65 | 6.44 | 5.89 | 6.40 | 5.15 | 5.72 | 9.13 | 3.22 | 1.79 | 7.81 | |
| 31.61 | 26.31 | 27.39 | 21.76 | 18.64 | 43.99 | 25.37 | 4.44 | 14.61 | 14.48 | 8.74 | 6.79 | 19.67 | |
| -25.81 | -20.93 | -23.65 | -18.75 | -17.52 | -42.75 | -25.37 | -4.44 | -14.61 | -14.48 | -8.74 | -6.79 | -19.67 | |
| 0.22 | 0.20 | 0.18 | 0.16 | 0.13 | 0.10 | 0.06 | 0.05 | 0.03 | 0.01 | 0.49 | 0.45 | 0.74 | |
| -23.34 | -18.65 | -21.76 | -17.16 | -16.15 | -41.84 | -24.58 | -3.41 | -14.58 | -19.11 | -8.94 | -6.68 | -21.12 | |
| -0.03 | -1.81 | -0.05 | – | – | – | – | – | – | – | – | – | – | |
| -23.34 | -18.65 | -21.76 | -17.16 | -16.15 | -41.84 | -24.58 | -3.41 | -14.58 | -19.11 | -8.94 | -6.68 | -21.12 | |
| -23.09 | -18.43 | -21.55 | -16.98 | -16.00 | – | -24.50 | -3.35 | -14.55 | -19.09 | -8.26 | -5.96 | -20.02 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.